SEP 06, 2020 8:44 AM PDT

Focal HIFU ablation improves prostate cancer patients' quality of life

Research published in The Journal of Urology offers an alternative to invasive prostate cancer treatments like surgery and radiation. Standard treatments can have serious side effects such as urinary incontinence or impotency; the new alternative, called focal or targeted high-intensity focused ultrasound (HIFU) ablation, offers a means of improving the quality of life for prostate cancer patients. The study comes from collaborating scientists from USC Urology and Keck Medicine of USC.

The study followed 100 men in the US who received focal HIFU ablation as an outpatient procedure during the time period of 2015-2019. The procedure is relatively fast, lasting approximately only two hours, during which time a focused ultrasound beam is used to raise the temperature inside the prostate to 90 degrees Celsius in order to kill targeted areas of prostate tissue.

Following the results of the study, patients receiving focal HIFU ablation had shorter recovery times compared to patients who underwent surgery and or radiation. Focal HIFU ablation was also an appropriate means of primary treatment, given that 91% of HIFU patients were able to avoid surgery or radiation. According to the researchers, 73% of patients did not experience treatment failure, which they categorized as cancer recurrence, metastases or mortality, or the need for additional hormone therapy, chemotherapy, surgery or radiation.

"This positive data empowers urologists to use focal HIFU ablation to effectively address prostate cancer without the intrinsic side effects of radical treatments," says first author Andre Abreu, MD, who is a urologic surgeon with Keck Medicine. "We hope this study encourages prostate cancer patients to talk to their doctor about all potential treatment options to ensure that they receive a personalized care plan that addresses their individual needs."

Photo: Pixabay

While this type of treatment has been available for a long time, only recently was it approved by the FDA (in 2015). Given the study’s positive results, the researchers say they anticipate the treatment will become common as precision medicine becomes more advanced.

"Throughout screening, diagnosis and treatment, it is important to balance accuracy and efficacy. Our physicians will continue working toward better methods to personalize that balance for every prostate cancer patient," comments senior author Inderbir S. Gill, MD, founding and executive director of USC Urology.

Sources: The Journal of Urology, Eureka Alert

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
MAY 06, 2021
Cell & Molecular Biology
Improved Genetic Technologies Find Elusive Genetic Mutations
MAY 06, 2021
Improved Genetic Technologies Find Elusive Genetic Mutations
Some genetic diseases are caused by inborn errors - genetic mutations that we're born with and that end up in every cell ...
MAY 08, 2021
Cancer
More evidence supports the evils of sugary drinks
MAY 08, 2021
More evidence supports the evils of sugary drinks
New research published online in the journal Gut from researchers at the Washington University School of Medicine i ...
JUN 12, 2021
Cancer
Using astronomy to image cancer tumors
JUN 12, 2021
Using astronomy to image cancer tumors
In an interdisciplinary breakthrough, a recent study published in Science describes the development of a new platform, d ...
JUN 18, 2021
Cancer
Cancer cell lines are too dissimilar from human cancer cells
JUN 18, 2021
Cancer cell lines are too dissimilar from human cancer cells
A new study finds cultured cancer cells lack genetic similarity to humans. This is concerning because cancer cell lines ...
JUN 27, 2021
Cancer
Are e-cigarettes actually helpful for smoking cessation?
JUN 27, 2021
Are e-cigarettes actually helpful for smoking cessation?
New research published in The Lancet Public Health reports on a study that looked at interventions targeting e-cigarette ...
JUL 23, 2021
Cancer
New Drug Eradicates Breast Cancer Tumors in Days
JUL 23, 2021
New Drug Eradicates Breast Cancer Tumors in Days
A new drug can kill between 95 and 100% of cancer cells in mice with human estrogen-receptor-positive breast cancer. The ...
Loading Comments...